• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Sanofi-Aventis ADR

Sanofi-Aventis ADR

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Sanofi H1 2015 Results - Interview with CEO Olivier Brandicourt

    Sanofi H1 2015 Results - Interview with CEO Olivier Brandicourt

  2. Rentrak Announces Official Worldwide Box Office Results for Weekend of July 26, 2015

    Rentrak Announces Official Worldwide Box Office Results for Weekend of July 26, 2015

  3. Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration

    Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration

  4. Genzyme Strengthens Endocrinology Portfolio with Acquisition of Rare Disease Therapy Caprelsa® (vandetanib) from AstraZeneca

    Genzyme Strengthens Endocrinology Portfolio with Acquisition of Rare Disease Therapy Caprelsa® (vandetanib) from AstraZeneca

  5. ADRs End Lower; ASML Rises

    ADRs End Lower; ASML Rises

  6. Rentrak Announces Official Worldwide Box Office Results for Weekend of July 12, 2015

    Rentrak Announces Official Worldwide Box Office Results for Weekend of July 12, 2015

  7. Merial Introduces Oravet® Dental Hygiene Chews for Dogs

    Merial Introduces Oravet® Dental Hygiene Chews for Dogs

  8. Regeneron and Sanofi Announce Phase 3 Results Showing LDL-C Reductions of More Than 60 Percent in Japanese Patients Treated with Praluent® (alirocumab) Injection

    Regeneron and Sanofi Announce Phase 3 Results Showing LDL-C Reductions of More Than 60 Percent in Japanese Patients Treated with Praluent® (alirocumab) Injection

  9. Rentrak Announces Official Worldwide Box Office Results for Weekend of July 5, 2015

    Rentrak Announces Official Worldwide Box Office Results for Weekend of July 5, 2015

  10. Sanofi Gets Approval from Japan for Toujeo Diabetes Drug

    Sanofi Gets Approval from Japan for Toujeo Diabetes Drug

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.